Shining on Major News : Amgen Inc. (NASDAQ:AMGN), Digi International Inc. (NASDAQ:DGII), Meritage Homes Corporation (NYSE:MTH), ERBA Diagnostics, Inc. (NYSEMKT:ERB), WESCO International (NYSE:WCC)

On SEP 5, Amgen Inc. (NASDAQ:AMGN) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept. 10, 2014, at the Grand Hyatt New York in New York City, beginning at 9:10 a.m. ET. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference.  Amgen Inc. (NASDAQ:AMGN) belongs to Healthcare sector. Its net profit margin is 25.70% and weekly performance is -0.58%. On last trading day company shares ended up $137.88. Amgen Inc. (NASDAQ:AMGN) distance from 50-day simple moving average (SMA50) is 9.59%.

On AUG 27, Digi International Inc (NASDAQ:DGII) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a research noteissued to investors on Tuesday. The firm currently has a $8.60 price objective on the stock. Zacks‘s price objective points to a potential upside of 2.02% from the stock’s previous close. Digi International Inc. (NASDAQ:DGII) shares increased 0.36% in last trading session and ended the day at $8.36. DGII Gross Margin is 48.20% and its return on assets is 1.10%. Digi International Inc. (NASDAQ:DGII) quarterly performance is -9.82%.

On AUG 26, Meritage Homes Corporation (NYSE:MTH) has received a consensus recommendation of “Hold” from the ten ratings firms that are currently covering the stock,Analyst Ratings Net reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and five have issued a buy recommendation on the company. On 05 September, Meritage Homes Corporation (NYSE:MTH) shares fell -0.18% and was closed at $39.83. MTH EPS growth in last 5 year was 18.40%. Meritage Homes Corporation (NYSE:MTH) year to date (YTD) performance is -17.00%.

ERBA Diagnostics, Inc. (NYSEMKT:ERB), a fully integrated in vitro diagnostics company, on AUG 12 announced its results of operations for the second quarter of 2014. Net income increased to $450,436 for the second quarter of 2014, or earnings of $0.01 per diluted share, compared to net income of $87,333 for the second quarter of 2013, or earnings of $0.00 per diluted share. Total revenues increased to $7,540,657 for the second quarter of 2014, a 9.5% increase, compared to $6,889,259 for the second quarter of 2013. ERBA Diagnostics, Inc. (NYSEMKT:ERB) ended the last trading day at $3.23. Company weekly volatility is calculated as 6.98%and price to cash ratio as 52.49. ERBA Diagnostics, Inc. (NYSEMKT:ERB) showed a weekly performance of -10.53%.

On JULY 25, WESCO International Inc. (NYSE:WCC)’s second quarter 2014 earnings of $1.29 cents per share missed the Zacks Consensus Estimate by 4 cents. However, earnings increased 32.5% sequentially and 3.0% on a year-over-year basis. Improved sales volumes in Canada, acquisition pipeline, organic sales growth and better pricing led to the increase in bottom line performance. WESCO International Inc. (NYSE:WCC) shares fell -1.11% in last trading session and ended the day on $83.79. WCC Gross Margin is 20.40% and its return on assets is 5.20%. WESCO International Inc. (NYSE:WCC) quarterly performance is -8.12%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone